Corporate Governance

Board of Directors

Pursuant to Aiforia’s Articles of Association, the company’s Board of Directors comprises from four to seven members and the term of office of Board members ends at the close of the Annual General Meeting following their election. The Board of Directors constitutes a quorum when more than half of its elected members are present. Members with a conflict of interest are excluded when determining the quorum.

Duties of the Board of Directors

In addition to the duties defined in laws and regulations and Aiforia’s Articles of Association, the duties of Aiforia’s Board of Directors include the following:

to guide and supervise Aiforia's management and operations;
to decide on significant matters pertaining to Aiforia's operations;
to review and approve Aiforia's half-yearly reports, annual reports and financial statements;
to determine and approve Aiforia's strategy, operating plan and certain policies and practices of Aiforia, as well as to monitor their implementation;
to decide on significant business acquisitions, investments and divestments; and
to define Aiforia's dividend policy.

Aiforia's Board of Directors convenes according to a schedule agreed in advance and as needed.

The Board of Directors of Aiforia has a Remuneration Committee and an Audit Committee.

Board members

Pekka Mattila, born 1959

Chairman of the Board of Directors since 2013
Finnish citizen
Master of Science in Biochemistry, Biotechnology and Microbiology
Independent of the company and significant shareholders
Company shares: 835,166 (includes also indirect ownership through Musta Aukko Oy)
Company options: 160,000 pc

Relevant work experience

Desentum Oy, CEO since 2011

Current positions of trust

Aiforia Technologies Oyj, Chairman of the Board
TILT Biotherapeutics Oy Board member since 2020
Medix Biochemica Group Oy, Board member since 2008
Rotundus Oy, Board member since 2015 (a family investment company)
Musta Aukko Oy, Board member since 2015 (a family investment company)
Saccus Medicae Oy, Board member since 2015 (a family investment company)
Hautova Kana Oy, Board member since 2015 (a family investment company)
TJT Technologies Oy, Deputy member of the board since 2016
Asunto Oy Helsingin Perla, Board member since 2022
Master Golf Course Oy Ab, Chairman of the Board since 2014

Previous positions of trust

Herantis Pharma Oy, Chairman of the Board of Directors (ended in 2020)
Mobidiag Oy, Member of the Board of Directors (ended in 2021)

Johan Lundin, born 1964

Member of the Board of Directors since 2013
Finnish citizen
M.D., PhD
Independent of significant shareholders but not independent of the company
Company shares: 1,264,300
Company options: 20,000 pc

Relevant work experience

Aiforia Technologies, Scientific Advisor since 2021
Finnish Institute of Molecular Medicine at the University of Helsinki, Research Director and a member of the steering group since 2011
Karolinska Institute, Professor of Medical Technology since 2019
Aiforia Technologies, Scientific Director, 2013–2019

Current positions of trust

Member of the Committee of Advisors of the European Society of Digital and Integrative Pathology since 2016

Maria Fe Paz de Paz, born 1978

Member of the Board of Directors since 2022
Spanish citizen
M.D., PhD MBA
Independent of the company and significant shareholders
Company shares: 0
Company options: 0

Relevant work experience

Article25 Capital, Founder and General Partner since 2019
Inflection Point Biomedical Advisors, Founder and President since 2015
Rosetta Genomics, Chief Medical Officer, 2015–2016
Diaceutics, Chief Medical officer and Founder, 2009–2016
Labceutics, President and Founder, 2009–2015

Current positions of trust

Connect by Circular Lab, Founder and Chairwoman since 2020
European Commission, External Advisor since 2015

Previous positions of trust

Diaceutics, Member of the Board of Directors 2009–2016

Jerry Jian Hong, born 1975

Member of the Board of Directors since 2022
Chinese citizen
MBA
Independent of the company but not independent of significant shareholders
Company shares: 0
Company options: 0

Relevant work experience

CEO Ascend Capital, Managing Director Ascend Tapio/Artemis S.a.r.L since 2020
Vice president of SAIC Europe and Managing Director of SAIC Mobility Europe, 2018–2020
Assistant President and Executive director, Business Development, SAIC Europe, Managing Director, SAIC Mobility Europe, 2013–2018

Steven Lynum, born 1969

Member of the Board of Directors since 2023
Canadian citizen
BCMAS, BBA
Independent of significant shareholders but not independent of the company
Company shares: 0
Company options: 0

Relevant work experience

PHC Holdings Corporation, Corporate Officer & Co-Head Diagnostics & Life Sciences Domain since 2023
Epredia Holdings (a PHC Group company), President since 2022
PHC Corporation (Japan), Executive Director, Global Business Development, 2019–2022
Panasonic Healthcare, President, 2018–2019
Panasonic Healthcare Corporation of North-America, President and other senior management roles, 1991–2018

Tuomas Tenkanen, b. 1961

Member of the Board of Directors since 2024
Finnish Citizen
Master of Science in Technology
Independent of the company and significant shareholders
Company shares: 276,721 (ownership through Tjt Technologies Oy)
Company options: 35,000 pc

Relevant work experience

President, TJT Technologies Oy, 2011–
Managing director, TJT Technologies Oy, 2023–
CEO, Mobidiag, 2013–2022
Director R&D, Finnzymes, 1993–2010
Production Manager, Finnzymes, 1989–1993

Current positions of trust

TJT Technologies Oy, member of the board, 2011–

Previous positions of trust

Mobidiag Oy, member of the board 2013–2022
LS CancerDiag, member of the board 2022–2023
Aiforia Technologies Oy, board member 2013–2017

Committees

Read about our committees

Management ownership

See share ownership of board members